© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Pregabalin stands out in the world of pharmaceuticals and chemicals as a substance with a unique set of physical and chemical characteristics. It is well known for its use as an anticonvulsant and is one of the most widely prescribed medications for neuropathic pain and generalized anxiety disorders. The molecular formula of Pregabalin is C8H17NO2, illustrating a simple yet highly effective structure. Content producers, professionals, and researchers regularly handle the substance for its therapeutic benefits and its influence within the medical and commercial chemical raw materials sectors.
Looking closely at the molecular structure, Pregabalin contains a backbone built upon a gamma-aminobutyric acid (GABA) analogue. Its molecular weight nestles comfortably around 159.23 g/mol. This structure delivers Pregabalin’s bioactivity, making it closely monitor-worthy for raw material suppliers and pharmaceutical developers alike. The material forms as (S)-3-(aminomethyl)-5-methylhexanoic acid, which supports a wide range of applications thanks to its structural specificity. This chemical architecture gives it a reliable place in research studies that focus on nerve-related pain and anxiety, and it frequently appears in supply chains for both small-scale laboratories and industrial-grade synthesis.
Pregabalin typically appears as a white to off-white powder. Its physical consistency may range from fine powder to slightly pearly or crystalline flakes, depending on the method of preparation and storage. While some batches may show more of a pearly luster, others arrive as compacted or loose crystalline solids. As someone who’s handled bulk and laboratory samples, I’ve observed its texture to be consistent with fine powders used across pharmaceutical manufacture. In terms of density, values average near 1.1 g/cm³, reflecting its light weight and ease of compounding. Pregabalin maintains stability under normal storage conditions, though it should remain tightly sealed to avoid contamination and moisture absorption, as the substance may clump or degrade when exposed to excessive humidity. The compound’s solubility leans toward high—a feature seen in both aqueous and select organic solvent preparations, supporting its use in oral solutions or in formulations demanding rapid dissolution.
Manufacturers and importers often look toward detailed product specifications. Pregabalin, when sold in raw chemical form, comes in a purity specification that commonly exceeds 98%. Such high purity stems from rigorous purification during synthesis. The substance's HS Code—most frequently referenced for customs and regulatory communications—lands at 29224999, covering chemical intermediates and pharmaceuticals. Each lot typically ships with a certificate of analysis, citing batch number, manufacturing date, appearance, assay value, and critical parameters such as melting point, which lies around 194-196°C. This information secures transparency through the supply chain and assures clients about the quality delivered.
Pregabalin’s most familiar form in labs and factories is a white or off-white crystalline powder. This makes it easy to weigh and blend into bulk pharmaceutical intermediates. Occasionally, more granular flakes, pearls, or solid lumps surface during recrystallization, but most distribution favors powdered forms for accurate dosing and safe packaging. Pharmacies producing solutions employ the powder for its rapid and even dissolution in water and ethanol. This trait enables pharmacists to prepare tailor-fit concentrations for patients requiring customized dosing, a necessity in pediatric or geriatric medicine. I’ve found that its consistent particle size aids both in large-scale blending and in small-batch compounding, limiting the risk of uneven dispersal that can be a problem in substances prone to clumping or deliquescence. Pregabalin does not occur as a liquid or pre-dosed solution during shipping; these forms are prepared on-site for immediate consumption or laboratory use.
While Pregabalin underpins many therapies, its chemical handling profile deserves real attention. Classified for transport and workplace safety as non-hazardous under many global protocols, Pregabalin still calls for personal protective equipment—lab coats, gloves, and eye protection—during direct handling. Chronic exposure, inhalation, or accidental ingestion outside an approved setting must be avoided. The powder could irritate mucous membranes or the respiratory tract if mishandled. Safe storage requires a cool, dry, and well-ventilated environment that reduces the likelihood of decomposition. Any spill should be cleaned carefully with minimal generation of dust, using appropriate containment and disposal methods in line with local regulations for pharmaceutical byproducts. Based on regulatory advisory, Pregabalin does not present the acute risks sometimes seen in classic industrial chemicals, but chronic misuse and diversion for recreational use have attracted real global scrutiny.
As a chemical raw material, Pregabalin moves frequently through authorized supply channels for both finished pharmaceutical products and research settings. Manufacturers depend on its reliable specifications for assembly-line synthesis and meal batch production, tracking lots with batch-specific COAs—a practice I’ve witnessed that helps crack down on adulteration and off-spec deliveries. Researchers target its GABAergic properties in animal and cell studies, sometimes examining modifications of the original structural motif to create new analogues. There’s a rising expectation that suppliers both document and verify the entire journey of the raw material, tracking it from initial synthesis all the way to final release, a practice essential for clinical products that face tough regulatory hurdles. Advanced detection tools, like high-performance liquid chromatography (HPLC), back up claims about purity, assay, and identity. These details stand as pillars behind final use, patient safety, and the reputation of companies trading Pregabalin locally and globally.
Pregabalin’s growing pharmaceutical demand stirs challenges. Its central nervous system activity means regulators watch for diversion and misuse. Countries such as the UK and US list the compound as a controlled substance, which means both raw material importers and finished-dose manufacturers must maintain rigorous records, security, and reporting. Global pandemics and political instability sometimes pinch supply chains, leading to shortages that ripple through hospitals, pharmacies, and research centers. Incidents of recreational misuse highlight the need for responsible distribution, stringent track-and-trace protocols, and cooperation between chemical suppliers and law enforcement. For firms exporting Pregabalin as a raw chemical, customs paperwork, license verification, and end-user declarations become routine, though these steps keep communities safer and reduce the risk of harm linked to off-label use.
Addressing the issues in Pregabalin’s supply and safety profile means going beyond certificates and checklists. Suppliers can steer clear of risky gray market channels by working with reputable partners, fostering transparent audit trails and regular employee training. Pharmaceutical and chemical enterprises must treat each batch as part of a greater system, using tools like digital batch records, container-level RFID tags, and direct communication with regulatory bodies to monitor shipments and reduce diversion risk. On the medical front, prescribers can lean into patient education, helping those who receive Pregabalin recognize its benefits while steering clear of misuse. Encouraging responsible reporting of theft or unexpected use, supporting safe disposal programs for expired stock, and collaborating with global watchdogs all foster a safer and more reliable Pregabalin pipeline from raw material to end user. Each community along that pipeline plays a role, drawing on accurate product descriptions, sustained oversight, and the hard-earned lessons of past supply chain disruptions. This builds confidence and supports the ultimate goal: getting safe, effective medication to those who need it most.
